Jui-Sheng Hsu

Title: Innovations of Jui-Sheng Hsu in Optical Imaging

Introduction

Jui-Sheng Hsu is an accomplished inventor based in Kaohsiung, Taiwan. He has made significant contributions to the field of optical imaging, particularly in the development of diagnostic agents for prostate cancer. His innovative work has the potential to enhance the accuracy of prostate cancer diagnostics.

Latest Patents

Jui-Sheng Hsu holds a patent for "Prostate-specific antigen probes for optical imaging." This invention provides a novel probe that contains a prostate peptide substrate. The probe can be utilized as a prostate diagnostic agent for optical imaging. An 11 amino acid peptide substrate is synthesized for specific prostate-specific antigen (PSA). This protected graft copolymer (PGC) consists of a poly-L-lysine (PL) backbone and methoxypoly(ethylene glycol) (MPEG). Two terminals of the peptide substrate are bound to poly-L-lysine and Cy5.5 fluorochrome. This probe will be used as a NIR (near-infrared fluorescence) probe for optical imaging. Jui-Sheng Hsu has 1 patent to his name.

Career Highlights

Jui-Sheng Hsu is affiliated with Kaohsiung Medical University, where he conducts his research and development work. His contributions to the field of optical imaging have been recognized for their potential impact on medical diagnostics.

Collaborations

Jui-Sheng Hsu has collaborated with notable colleagues, including Gin-Chung Liu and Yun-Ming Wang. Their teamwork has fostered advancements in the field of optical imaging and prostate cancer diagnostics.

Conclusion

Jui-Sheng Hsu's innovative work in developing prostate-specific antigen probes represents a significant advancement in optical imaging technology. His contributions are poised to improve diagnostic capabilities in the medical field.